AzTrials
AzTrials

Post Operative AnalgesiaNCT07463482

Preoperative High-Dose Oral Paracetamol for Postoperative Analgesia in Children Undergoing Tonsillectomy"

A study testing Paracetamol (acetaminophen) in people with Post Operative Analgesia and Tonsillectomy With or Without Adenoidectomy, run by Thammasat University at 1 site in Thailand.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized clinical trial compares two different preoperative doses of oral paracetamol (acetaminophen) in children undergoing elective tonsillectomy. The aim is to determine whether a higher loading dose (30 mg/kg) decreases the need for opioid rescue medication after surgery compared with the standard dose (15… Read more about this study

Who is it for?
Ages 3 to 15 years
What is being tested?
Paracetamol (acetaminophen)
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
54 participants
Where
1 siteThailand
Study dates
Mar 2026to Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 15 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children aged 3 to 15 years
  • ASA physical status I-III
  • Scheduled for elective tonsillectomy with or without adenoidectomy

Who cannot join

  • Known allergy or contraindication to paracetamol or any agents in the study protocol
  • Chronic opioid use

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Waranya Lertpaitoonpan, MD contact

+66892039291

waranya.anesthtu@gmail.com

Thailand1 site
  • Thammasat University

    Pathum Thani, Changwat Pathum Thani, 12120

    Waranya Lertpaitoonpan, MD, +66892039291, waranya.anesthtu@gmail.com

Other trials in Thailand

About this study

Official title: Effect of Preoperative Oral Paracetamol Loading Dose Versus Standard Dose on Postoperative Opioid Consumption in Pediatric Tonsillectomy With Multimodal Analgesia: A Randomized Controlled Trial

This randomized clinical trial compares two different preoperative doses of oral paracetamol (acetaminophen) in children undergoing elective tonsillectomy. The aim is to determine whether a higher loading dose (30 mg/kg) decreases the need for opioid rescue medication after surgery compared with the standard dose (15 mg/kg), when used as part of a multimodal pain management approach. Children aged 3 to 15 years will be randomly assigned to receive either 30 mg/kg or 15 mg/kg of oral paracetamol before surgery. All participants will receive the same standard anesthesia and postoperative pain management. The primary outcome is the total amount of rescue opioid (fentanyl) required during the first 12 hours after surgery. Secondary outcomes include postoperative pain scores and the occurrence of side effects such as nausea and vomiting. This study seeks to determine whether a higher initial dose of paracetamol offers additional clinical benefits in pediatric tonsillectomy with multimodal analgesia.

Read the detailed description

Tonsillectomy is one of the most commonly performed surgical procedures in children, yet it is often associated with significant postoperative pain. Effective pain management is critical to minimizing complications, and a multimodal approach to analgesia is recommended to reduce opioid consumption while providing effective pain relief. Paracetamol is a widely used and safe analgesic component within these multimodal regimens.

While previous studies indicate that an oral paracetamol loading dose of 30 mg/kg effectively reduces fever and provides consistent serum levels, there remains a limited direct comparison of clinical outcomes between an oral preoperative loading dose and a standard dose within preemptive standardized multimodal analgesia protocols for pediatric tonsillectomy. This randomized controlled trial aims to evaluate whether an oral paracetamol loading dose yields a superior opioid-sparing effect compared to a standard dose in this patient population.

A total of 54 pediatric patients, aged 3 to 15 years with ASA physical status I-III, scheduled for elective tonsillectomy (with or without adenoidectomy) will be enrolled. Participants will be randomized in a 1:1 ratio into two groups:

Group L (Loading Dose): Will receive a preoperative oral paracetamol dose of 30 mg/kg (adjusted body weight, maximum 1000 mg) 30-60 minutes before anesthesia induction.

Group C (Standard Dose): Will receive a preoperative oral paracetamol dose of 15 mg/kg (maximum 1000 mg) 30-60 minutes before anesthesia induction.

To maintain strict quadruple blinding, both groups will receive the same commercial paracetamol syrup formulation (250 mg/5 mL) prepared in opaque oral syringes by independent research staff. Participants, caregivers, treating anesthesiologists, surgeons, and outcome assessors (ward nurses) will be blinded to the group allocation.

All participants will undergo general anesthesia with endotracheal intubation and receive a standardized multimodal analgesia protocol. This protocol includes preoperative ibuprofen (10 mg/kg), intraoperative IV dexamethasone (0.2 mg/kg), local infiltration with 1% lidocaine with epinephrine, IV ondansetron (0.1 mg/kg), and postoperative oral paracetamol (15 mg/kg every 6 hours), ibuprofen (10 mg/kg every 8 hours).

Postoperative pain will be evaluated using age-appropriate validated tools: the revised FLACC scale for children aged 3-7 years (or those with cognitive impairment) and the Numerical Rating Scale (NRS) for children aged 7-15 years. Pain assessments will occur upon arrival at the post-anesthesia care unit (PACU) (hour 0), before transfer to the ward (hour 1), and at 6 and 12 hours postoperatively on the ward. If a patient reports a pain score of 4 or greater, rescue IV fentanyl (0.25 mcg/kg) will be administered according to protocol guidelines.

The primary outcome of the study is the total postoperative opioid (fentanyl) consumption within the first 12 hours after surgery. Secondary outcomes include postoperative pain scores at multiple time points, time to first rescue opioid requirement, the number of rescue opioid doses administered, and the incidence of adverse events such as nausea, vomiting, and sedation. The observation window is confined to the initial 12 hours post-surgery because most patients are discharged within 24 hours without oral opioid prescriptions, and the drug's pharmacological effects are expected to be most pertinent during this early recovery phase.

Being tested
Paracetamol (acetaminophen)
Keywords
paracetamol, acetaminophen, tonsillectomy, postoperative analgesia, pediatric anesthesia, multimodal analgesia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Paracetamol (acetaminophen)Drug

    Oral paracetamol administered preoperatively as a single dose ( 15 mg/kg or 30 mg/kg, depending on assigned arm).

Study groups in NCT07463482
Study groupRoleWhat they receive
High-dose oral paracetamol (30 mg/kg)ExperimentalParticipants receive oral paracetamol 30 mg/kg approximately 30-60 minutes before surgery.
Receives: Drug: Paracetamol (acetaminophen)
Standard-dose oral paracetamol (15 mg/kg)Active comparatorParticipants receive oral paracetamol 15 mg/kg approximately 30-60 minutes before surgery.
Receives: Drug: Paracetamol (acetaminophen)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total postoperative opioid consumption

    Total postoperative opioid consumption (expressed as cumulative IV fentanyl dose in mcg/kg) was administered.

    Measured: 0-12 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Mar 2026
  2. Study startMar 2026 (estimated)
  3. Primary completionSep 2026 (estimated)
  4. Study completionNov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
54 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07463482
Sponsor's protocol ID
MTU-EC-AN-0-306/68
Status last verified
Mar 2026
First submitted
5 Mar 2026
Last updated
11 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Paracetamol (acetaminophen) in people with Post Operative Analgesia and Tonsillectomy With or Without Adenoidectomy, run by Thammasat University at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 11 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Waranya Lertpaitoonpan, MD (+66892039291, waranya.anesthtu@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total postoperative opioid consumption (time frame: 0-12 hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in